Assignee
AMRYT PHARMACEUTICALS INC
US·3 granted patents·5 pending applications·0 citations·filing 2020–2025
Top patents by PatentIndex Score
8 records- 0179US2023115655A1Engineered polypeptides having enhanced duration of actionAMRYT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0269US2023314447A1Methods of detecting anti-leptin neutralizing antibodiesAMRYT PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0368US11535659B2Engineered polypeptides having enhanced duration of actionAMRYT PHARMACEUTICALS INC·Filed 2020·Granted Dec 27, 2022·0 cites·8 claims
- 0461US2025155450A1Methods of detecting anti-leptin neutralizing antibodiesAMRYT PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0560US12472172B2Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patientsAMRYT PHARMACEUTICALS INC·Filed 2023·Granted Nov 18, 2025·0 cites·24 claims
- 0660US11709166B2Methods of detecting anti-leptin neutralizing antibodiesAMRYT PHARMACEUTICALS INC·Filed 2020·Granted Jul 25, 2023·0 cites·17 claims
- 0748US2023285376A1Lomitapide for use in methods of treating hyperlipidemia and hypercholesterolemia in pediatric patientsAMRYT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 0839US2024165093A1Methods for treating familial chylomicronemia syndromeAMRYT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →